The Potential for Faricimab in the treatment of Central Serous Chorioretinopathy

11 min•12 december 2024

Om avsnittet

Dr. Elizabeth Rossin discusses her new study based on genetic background data demonstrating the effect of Faricimab in CSR.

Fler avsnitt

American Journal of Ophthalmology Podcasts Collection med Various finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.

The Potential for Faricimab in the treatment of Central Serous Chorioretinopathy

Om avsnittet

Fler avsnitt

The Founding of Women in Ophthalmology

Botox vs Strabismus Surgery for Comitant Esotropia

Novel Risk Factor for Severe Glaucoma- Social Vulnerability Index

Compassionomics - The Science of Caring

Mortality Risk with Retinal Vein Occlusion

Is Regional Anesthesia Safe for Open Globe Repair?

What are the Missing Elements In Surgical Clinical Trials?

Does Cataract Surgery Lower the Eye Pressure?

Shunt for Pediatric Glaucoma

The Ophthalmologist's Role in the Opioid Crisis